WANJIRU LANDERS: Open Payments
NPI 1881160356 · OWASSO, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 18 payments from 7 companies in 2025. Trend: 2023 $67 · 2024 $350 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $118 |
| Teva Pharmaceuticals USA, Inc. | 4 | $78 |
| Neurocrine BioSciences, Inc. | 3 | $64 |
| Lundbeck LLC | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| ABBVIE INC. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: ARISTADA, UZEDY, INGREZZA, REXULTI, INVEGA SUSTENNA, VRAYLAR, Auvelity.
Industry payments across OK — which companies pay providers there.
